Effect of Cryotherpy on Hypertrophic Scar

Status Active, not recruiting

Clinical Trial Summary

Purpose of the study:

The purpose of the study is to evaluate the therapeutic effect of cryotherpy in treating hypertrophic scar.

It will be hypothesized that:

Cryotherapy may not have an effect on hypertrophic scar.

Clinical Trial Description

The potential of cryotherapy application in vitro data indicated that using freezing treatment on VFFs + TGF-β1 (myofibroblast) modulated ECM turnover toward antifibrosis and normalization, attenuated myofibroblast differentiation, reduced cell migration, and weakened the contractile activity. On both VFFs ± TGF-β1, freezing treatment raised LP regeneration (HAS1, decorin).

The findings indicate that cryotherapy may play a protective role in scar formation and contribute to lamina regeneration.

Furthermore the need of this study was developed from the lack in the quantitative knowledge and information in the published studies about the effect of cryotherapy on hypertrophic scar.

This study will be designed to provide a guideline about the effect of effect of cryotherapy on hypertrophic scar height, thickness and discoloration, and to assist in planning an ideal treatment regimen for reducing hypertrophic scar.

Delimitations:

This study will be delimited in the following aspects:

1. Subjects:

Sixty patients suffering from hypertrophic scar will be randomly divided into two equal groups each one has 30 patients.

2. Equipment and tools:

2.1. Measurement equipment: Vancouver scar scale. MAPS (Matching Assessment of Scars and Photographs). 2.2. Therapeutic equipment: Gymna Cryoflow ICE-CT. Temperature resistant polymide tape (48 wide).

Hypothesis:

It will be hypothesized that:

Cryotherapy may not have an effect on hypertrophic scar.

Basic Assumptions:

It will be assumed that:

- All patients will receive the same kinds of medication and the same nursing care.

- All subjects are free from any chronic disease.

- All subjects will continue in the study.

- All patients will follow the instructions during the treatment ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04532840
Study type	Interventional
Source	Cairo University
Contact
Status	Active, not recruiting
Phase	Phase 2/Phase 3
Start date	April 15, 2019
Completion date	October 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00993005` - CICATRIX in the Treatment of Hypertrophic Scars and Keloids Scars	Phase 3
Withdrawn	`NCT02546076` - Comparison of Dual-mode ER:YAG Laser in Patients With Long Keloid/Hypertrophic Scars	Phase 2
Withdrawn	`NCT01858038` - Gene Expression During Surgical Scar Remodeling by Fractional Photothermolysis	N/A
Active, not recruiting	`NCT04389619` - Fractional Microneedling RF vs Intralesional Steroid With & Without Microneedling in Hypertrophic Scars	N/A
Active, not recruiting	`NCT01113125` - Scars After Central Venous Catheters	Phase 3
Active, not recruiting	`NCT00849004` - Prevention of Hypertrophic Scars or Keloids	N/A
Completed	`NCT00142441` - Effect of Pulse Width on Scar Treatment Using a 595-nm Pulsed Dye Laser	N/A
Completed	`NCT01078428` - Effect of Transparent, Self-drying Silicone Gel on the Treatment of Hypertrophic Abdominal Scars	Phase 4
Withdrawn	`NCT02655211` - Laser Induced Bioengineered Remodeling of Thermally Injured Skin Trial	N/A
Completed	`NCT02487212` - Treatment of Hypertrophic Scars Using Fractional Laser and Fractional Laser-assisted Topical Corticosteroid Delivery	Phase 4
Recruiting	`NCT00548210` - Effectivity of Dermatix in Promoting Scar Maturation	Phase 3